NCT04315857View on ClinicalTrials.gov

Study on Glycemic Variations in Diabetic Patients Treated With Chemotherapy: Benefit of Continuous Interstitial Glucose Measurement

CompletedOBSERVATIONAL
Enrollment

103

Participants

Timeline

Start Date

June 9, 2020

Primary Completion Date

April 6, 2022

Study Completion Date

April 6, 2022

Conditions
DiabetesChemotherapyInterstitial GlycemiaFreestyle
Interventions
OTHER

interstitial glycaemia

Continuous measurement of interstitial blood glucose during the first 15 days of the first two chemotherapy courses.

Trial Locations (1)

21000

Chu Dijon Bourgogne, Dijon

All Listed Sponsors
lead

Centre Hospitalier Universitaire Dijon

OTHER

NCT04315857 - Study on Glycemic Variations in Diabetic Patients Treated With Chemotherapy: Benefit of Continuous Interstitial Glucose Measurement | Biotech Hunter | Biotech Hunter